Advanced Filter

Filter by Group

Filter by Market Availability

Displaying drugs 6351 - 6375 of 8039 in total
Nivocasan has been used in trials studying the treatment of HCV Infection and Nonalcoholic Steatohepatitis.
Investigational
Matched Description: … Nivocasan has been used in trials studying the treatment of HCV Infection and Nonalcoholic Steatohepatitis …
Atreleuton has been used in trials studying the treatment of Atherosclerosis and Coronary Artery Disease.
Investigational
Matched Description: … Atreleuton has been used in trials studying the treatment of Atherosclerosis and Coronary Artery Disease …
Palomid 529 has been used in trials studying the treatment of Age-Related Macular Degeneration.
Investigational
Matched Description: … Palomid 529 has been used in trials studying the treatment of Age-Related Macular Degeneration. …
Cebranopadol has been used in trials studying the treatment of Pain, Neoplasms, and Chronic Pain.
Investigational
Matched Description: … Cebranopadol has been used in trials studying the treatment of Pain, Neoplasms, and Chronic Pain. …
Glial growth factor 2 has been used in trials studying the treatment of Heart Failure.
Investigational
Matched Description: … Glial growth factor 2 has been used in trials studying the treatment of Heart Failure. …
Levoglucose has been used in trials studying the diagnostic of Bowel Cleansing Prior to Colonoscopy.
Investigational
Matched Description: … Levoglucose has been used in trials studying the diagnostic of Bowel Cleansing Prior to Colonoscopy. …
Pactimibe has been used in trials studying the treatment of Atherosclerosis and Coronary Heart Disease.
Investigational
Matched Description: … Pactimibe has been used in trials studying the treatment of Atherosclerosis and Coronary Heart Disease …
Berkelium is under investigation in clinical trial NCT02189122 (Comparative Effects of Aspirin and NHP-544C).
Investigational
Matched Description: … Berkelium is under investigation in clinical trial NCT02189122 (Comparative Effects of Aspirin and NHP …
Thioureidobutyronitrile has been used in trials studying the treatment of Solid Tumors and Ovarian cancer.
Investigational
Matched Description: … Thioureidobutyronitrile has been used in trials studying the treatment of Solid Tumors and Ovarian cancer …
Gossypol has been used in trials studying the treatment of Non-small Cell Lung Cancer.
Investigational
Matched Description: … Gossypol has been used in trials studying the treatment of Non-small Cell Lung Cancer. …
Pruvanserin has been used in trials studying the treatment of Sleep Initiation and Maintenance Disorders.
Investigational
Matched Description: … Pruvanserin has been used in trials studying the treatment of Sleep Initiation and Maintenance Disorders …
Fluocortin has been studied as a corticosteroid for treatment of dermatitis and eczema Spain .
Experimental
Matched Description: … Fluocortin has been studied as a corticosteroid for treatment of dermatitis and eczema Spain [A174817 …
Pimasertib is under investigation in clinical trial NCT01378377 (Combination Trial of Pimasertib (MSC1936369B) With Temsirolimus).
Investigational
Matched Description: … Pimasertib is under investigation in clinical trial NCT01378377 (Combination Trial of Pimasertib (MSC1936369B …
Masilukast is under investigation in clinical trial NCT01740986 (Safety and Efficacy of SA09012 in Asthma).
Investigational
Matched Description: … Masilukast is under investigation in clinical trial NCT01740986 (Safety and Efficacy of SA09012 in Asthma …
Poseltinib is under investigation in clinical trial NCT02628028 (A Study of LY3337641 in Rheumatoid Arthritis).
Investigational
Matched Description: … Poseltinib is under investigation in clinical trial NCT02628028 (A Study of LY3337641 in Rheumatoid Arthritis …
OM-85, a bacterial extract, is an immunomodulator of interferon-β production and inflammasome activity.
Investigational
Matched Description: … OM-85, a bacterial extract, is an immunomodulator of interferon-β production and inflammasome activity …
Phorbol 12-myristate 13-acetate diester is an inducer of neutrophil extracellular traps (NETs).
Investigational
Matched Description: … Phorbol 12-myristate 13-acetate diester is an inducer of neutrophil extracellular traps (NETs). …
EXOB-001 consists of extracellular vesicles derived from cultured human umbilical cord mesenchymal stromal cells.
Investigational
Matched Description: … EXOB-001 consists of extracellular vesicles derived from cultured human umbilical cord mesenchymal stromal …
EXT608 is a long-acting PTH derivative under investigation for the treatment of hyperparathyroidism.
Investigational
Matched Description: … EXT608 is a long-acting PTH derivative under investigation for the treatment of hyperparathyroidism. …
Putrescine is a toxic diamine formed by putrefaction from the decarboxylation of arginine and ornithine. Putrescine is a solid. This compound belongs to the polyamines. These are compounds containing more than one amine group. Known drug targets of putrescine include putrescine-binding periplasmic protein, ornithine decarboxylase, and S-adenosylmethionine decarboxylase proenzyme.
Experimental
Matched Description: … Putrescine is a toxic diamine formed by putrefaction from the decarboxylation of arginine and ornithine ... Known drug targets of putrescine include putrescine-binding periplasmic protein, ornithine decarboxylase …
MK-0354, is an orally administered drug candidate under development by Merck for the treatment of atherosclerosis and related disorders. It targets G protein-coupled receptor, or GPCR, that have the potential to regulate plasma lipid profiles, including HDL, or the good cholesterol, similar to the therapeutic action of niacin.
Investigational
Matched Description: … MK-0354, is an orally administered drug candidate under development by Merck for the treatment of atherosclerosis ... regulate plasma lipid profiles, including HDL, or the good cholesterol, similar to the therapeutic action of
PX-478 is a small molecule inhibitor of hypoxia inducible factor (HIF)-1 alpha currently in a clinical trial in patients with advanced metastatic cancer and lymphoma. PX-478 was effective in models of both non-small cell lung cancer and small cell lung cancer that express HIF-1 alpha.
Investigational
Matched Description: … PX-478 is a small molecule inhibitor of hypoxia inducible factor (HIF)-1 alpha currently in a clinical ... PX-478 was effective in models of both non-small cell lung cancer and small cell lung cancer that express …
MDI-P has demonstrated potent anti-HIV activity. MDI-P has been shown to be effective in killing HIV in cell culture. HIV is the virus that causes acquired immune deficiency syndrome (AIDS). MDI-P is also a potential therapeutic agent for the treatment of the symptoms of cystic fibrosis ("CF").
Investigational
Matched Description: … MDI-P is also a potential therapeutic agent for the treatment of the symptoms of cystic fibrosis ("CF …
Quaternium-18 is a mixture of quaternary ammonium chloride salts. Quaternium-18 Hectorite and Bentonite are the reaction products of Quaternium-18 with clays. These compounds are poorly absorbed through the skin. Acute oral and percutaneous toxicity tests in animals indicate that they exhibit little or no systemic toxic effects.
Experimental
Matched Description: … Quaternium-18 is a mixture of quaternary ammonium chloride salts. ... Quaternium-18 Hectorite and Bentonite are the reaction products of Quaternium-18 with clays. …
Alfaxalone, also known as alphaxalone or alphaxolone, is a neuroactive steroid and general anaesthetic. It is used in veterinary practice under the trade name Alfaxan, and is licensed for use in both dogs and cats. Along with alfadolone, it is also one of the constituents of anesthetic drug mixture althesin.
Vet approved
Matched Description: … Along with alfadolone, it is also one of the constituents of anesthetic drug mixture althesin. …
Displaying drugs 6351 - 6375 of 8039 in total